Why Nuvalent Inc (NUVL) Stock Is Rising
As of 2026-07-16, Nuvalent Inc (NUVL) has a next-year EPS growth estimate of 26.08%.
Why NUVL Stock Is Rising
- ·Current-Year Growth: Projected at 3.75%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 26.08%
- EPS growth this year
- 3.75%
- EPS next quarter (est)
- -$1.41
- Last price
- $123.96
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-16 | 26.08% | 3.75% | -$1.41 | $123.96 |
Screen Performance
Aggregate stats across all 1870 tickers our top-EPS-revision screen has flagged over the past 110 days.
- Median return since detection
- +2.2%
- % of tickers in the green
- 55%
- Median return on winners
- +20.4%
- Large revisions captured
- 1056
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Nuvalent Inc (NUVL) stock go up recently?▾
Nuvalent Inc (NUVL) stock has risen following an analyst upgrade of its next-year EPS growth estimate on 2026-07-16. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Nuvalent Inc's next-year EPS growth estimate?▾
As of 2026-07-16, Nuvalent Inc (NUVL) has a next-year EPS growth estimate of 26.08%, based on analyst consensus.
What sector and industry does Nuvalent Inc belong to?▾
Nuvalent Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NUVL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Nuvalent Inc (NUVL) appears here because it was detected by our daily top-EPS-revision-performer screen.